Short answer
aTYR PHARMA INC (ATYR) filed an 8-K current report with the SEC on May 15, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q1 2026 financial results released for quarter ended March 31, 2026.
aTYR PHARMA INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2026 financial results released for quarter ended March 31, 2026
- Full financial figures and management commentary in Exhibit 99.1 press release
- Results disclosure gives investors updated operating and financial condition information
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other aTYR PHARMA INC 8-K filings
Get the next ATYR 8-K as it lands
Follow ATYR for push alerts, or ask the research agent what this filing means.